RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • October 26th, 2018 • Zymeworks Inc. • Pharmaceutical preparations • New York
THIS RESEARCH AND LICENSE AGREEMENT (the “Agreement”), effective as of October 23, 2018 (the “Effective Date”), by and between LEO Pharma A/S, a corporation organized and existing under the laws of Denmark, with its principal business office located at Industriparken 55, 2750 Ballerup, Denmark (“LEO”) and ZYMEWORKS INC., a corporation organized and existing under the laws of British Columbia, having an address at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9 (“Zymeworks”). Zymeworks and LEO are each referred to, individually, as a “Party” and, together, as the “Parties.”
